Lumipulse® G β-Amyloid 1-40 CSF

Immunoreaction cartridges for research use with the LUMIPULSE G1200 for the quantitative measurement of β-amyloid 1-40 in human cerebrospinal fluid. (CSF)

The Lumipulse G β-Amyloid 1-40 assay is intended to be used in conjunction with Lumipulse G β-Amyloid 1-42 assay to determine the amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) in the clinical setting of dementia diagnosis.  

This CSF amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive decline.

The CSF amyloid ratio supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.

This product is For Research Use Only (RUO), not for use in diagnostic procedures.

Lumipulse® G β-Amyloid 1-40 Immunoreaction Cartridges

Product # 231685

3 x 14 Tests
Lumipulse® G β-Amyloid 1-40 Calibrators

Product # 231692

2 x 3 Concentrations
Lumipulse® G β-Amyloid Controls

Product # 231708

2 x 3 Concentrations
For research use only
Please contact your local Fujirebio representative for the availability of this product in your country.

  • Citations

    The BIOZ badges associated with Fujirebio products include peer-reviewed citations derived from scientific studies using Fujirebio products. Please note that the peer-reviewed citations do not reflect the regulatory status of Fujirebio products. Users should refer to the specific product documentation and any (clinical) claims made therein in order to ensure compliant use. For each country or geographic region, users must verify the related regulatory status of the Fujirebio product.

  • Insights

    • Upcoming webinars

    Neurodegenerative diseases
    2026/04/16 - 1:00 PM EST / 19:00 CET

    Alzheimer's Disease Blood Testing in Clinical Practice: How to Order, Interpret, and Act on Results

    View details

    Past webinars

    Neurodegenerative diseases
    Replay available
    2026/03/03 - 10:00 AM EST / 16:00 CET

    Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

    Explore session
    Neurodegenerative diseases
    Replay available
    2025/12/09 - 1:00 PM EST / 19:00 CET

    Demystifying Alzheimer’s Blood Biomarkers: What Every Clinician Needs to Know — A Complimentary Accredited Webinar

    Explore session
    Neurodegenerative diseases
    Replay available
    2025/11/19 - 10:00 AM EST / 16:00 CET

    Unlocking the biology of dementia with Lewy bodies: Biomarker insights from DDC to synapses

    Explore session

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.